Introduction

The Importance of Adherence

Factors Influencing Adherence

Measuring Adherence

HIV Therapy Adherence

Adherence Issues

Coping Strategies

References

Credits

References for Adherence

Next

1. Sumarjoto E. When tuberculosis treatment fails. A social behavioral account of patient adherence. Am Rev Respir Dis 1993;147;1311-20.
   
   
2. Eraker SD, Kirscht JP, Becker MH. Understanding and improving adherence. Annals of Internal Medicine 1984; 100: 258-286
   
   
3. Meichenbaum D, Turk DC. Treatment and adherence: terminology, incidence and conceptualisation. In. Facilitating treatment adherence. New York: Plenum; 1987. P19-39
   
   
4. Haynes RB. Determinants of adherence: the disease and the mechanics of treatment In. RB Haynes, DW Taylor, DC Sackett (eds) Adherence in Health Care. Baltimore: John Hopkins University Press;1979. P49-62
   
   
5. Conrad P. The meaning of medications: another look at adherence. Social Science Medicine 1985; 20(1):29-37
   
   
6. Donovan JL, Blake DR. Patient non-adherence: deviance or reasoned decision-making? Social Science Medicine 1992;34(5):507-513
   
   
7. Conrad P. The non-compliant patient in search of autonomy. Hastings Centre Report 1987;17(4): 15-17
   
   
8. Hunt LM, Jordan B, Irwin S, Browner CH. Adherence and the patient's perspective: controlling symptoms in everyday life. Cultural Medical Psychiatry 1989; 13:315-334
   
   
9. Eisen S, Miller D, Woodward R, et al. The effect of prescribed daily dose frequency on patient medication compliance. Ann Intern Med 1990;150;1881-1884.
   
   
10. Kruse W, Rampmaier J, Ullrich G, et al. Patterns of drug compliance with medications taken once and twice daily assessed by continuous electronic monitoring in primary care. Int J Clin Pharmacol Ther 1994;32:452-457
    
    
11. Mengden T, Binswanger B, Spuehler T, et al. The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening. J Hypertension 1993;11:1403-1411.
    
    
12. Rudd P, Ahmed S, Zachery V, et al. Improved compliance measures: applications in an ambulatory hypertensive trial. Clin Phrmacol Ther 1990;48:676-685.
    
    
13. Blaschke TF. Noncompliance and resistance to protease inhibitors. Washington 1997;abstract S43.
    
    
14. Broers B, Morabia A Hirschel B. A cohort study of drug users adherence with zidovudine treatment. Annals of Internal Medicine 1994;154:1121-1127
    
    
15. Samet JH, Libman H, Steger KA, Rajeev K. Adherence with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic. American Journal of Medicine 1992;92:495-502
    
    
16. Samuels JE, Hendrix J, Hilton M, Marantz PR, Sloan V, Small CB. Zidovudine therapy in an inner city population. Journal of Acquired immune Deficiency Syndromes 1990;3: 877-883
    
    
17. Eldred L, Wu A, Chaison RE, Moore RD. Adherence to antiretroviral therapy in HIV disease. Washington 1997;abstract 251.
    
    
18. Muma RD, Ross MW, Parcel GS, Pollard RB. Zidovudine adherence among indivudals with HIV infection AIDS Care 1995; 7(4):439-447.
    
    
19. Becker MH, Maiman LA. Strategies for enhancing adherence. Journal of Community Health 1980;6:113-135
    
    
20. Singh N, Squier C, Sivek C, Wagener M et al. Determinants of adherence with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing adherence. AIDS Care 1996;8(3) :261-269.
    
    
21. Griffith S. A review of factors associated with patient adherence and the taking of prescribed medicines. British Journal of General Practice 1990;40:114-116.
    
    
22. McMahon KM, Coyne N. Symptom management in patients with AIDS. Seminars in Oncological Nursing 1989;5:289-301.